A multi-center cross-sectional investigation of <i> BRAF</i> V600E mutation in Ameloblastoma
As a result of a notable prevalence of <i>BRAF</i> V600E in Thai individuals diagnosed with ameloblastoma, they may benefit from the utilization of adjunctive anti-BRAF targeted therapy for treatment.
Authors
- Wacharaporn Thosaporn
- Puangwan Lapthanasupkul (ORCID: https://orcid.org/0000-0001-7473-366X)
- Natchalee Srimaneekarn (ORCID: https://orcid.org/0000-0001-7454-1860)
- Anak Iamaroon (ORCID: https://orcid.org/0000-0002-8703-5083)
- Nakarin Kitkumthorn (ORCID: https://orcid.org/0000-0003-0616-6039)
- Sompid Kintarak (ORCID: https://orcid.org/0000-0001-9042-8446)
- Siwaporn Thanasan
- Poramaporn Klanrit
- Khin Mya Tun
Institutions
- Prince of Songkla University (TH)
- Khon Kaen University (TH)
- Mahidol University (TH)
- Rajavithi Hospital (TH)
- Chiang Mai University (TH)
Publication Details
- Journal
- PeerJ
- Published
- 2025-04-03
- DOI
- https://doi.org/10.7717/peerj.19137
- Primary Topic
- Oral and Maxillofacial Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00